MedTrace Logo

Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs)

NCT00822965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2016-01-07

No results posted yet for this study

Summary

The specific aims of the patient intervention are to:

1. increase patient knowledge about pacemakers (PM) and implantable cardioverter-defibrillators (ICDs)
2. help patients to identify if their PM or ICD has been interrogated
3. improve patient's physician-patient communication skills
4. teach patients how to identify if their device has been recalled
5. train patients what to do in case of a device recall

The educational interventions proposed, if proven to be effective by this pilot, will provide a low-cost, reproducible intervention to improve the clinical care and safe management of pacemakers (PM) and implantable cardioverter-defibrillators (ICD) in patients. The goal of the intervention will be to promote the safe use of implantable pulse generators.

Conditions

  • Pacemaker
  • Implantable Cardioverter-Defibrillators

Interventions

OTHER

Questionnaires

3 sets of questionnaires at the beginning of the study, at 2-months and at 4-months.

OTHER

Phone Interviews

2 follow-up phone interviews.

BEHAVIORAL

Educational Packet

Video or DVD of device information, updates, recalls, on-line resources and benefits of routine follow-up for device(s).

Sponsors & Collaborators

  • Mike Hogg Foundation

    collaborator UNKNOWN

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Maria Suarez-Almazor, MD, PhD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822965 on ClinicalTrials.gov